Clinical Trials Browser

Phase 2 × Primary Myelofibrosis × canakinumab × Clear all

NCT05467800 2026-05-07

Study of Canakinumab in Patients With Myelofibrosis

Phase 2 Active not recruiting

Primary Myelofibrosis